Bayer Corp., Agfa Div.
Bayer is a global company with core competencies in health and agriculture, committed to creating a better world through science, innovation, and sustainable development. The company focuses on improving health, providing high-quality food, and addressing major global challenges with innovative solutions. Bayer's diverse product portfolio includes well-known brands in pharmaceuticals, consumer health, and crop science, contributing to global health and nutrition. The company emphasizes research, innovation, and responsible practices, including the ethical use of animals in research and efforts to develop alternative methods. Bayer is dedicated to sustainability, safety, and transparency, actively engaging in community and environmental initiatives.
Industries
Nr. of Employees
Very Large (1000+)
Bayer Corp., Agfa Div.
Rothausstrasse 61, CH-4132 Muttenz
Patents
Combinations containing PVA and certain herbicides with improved properties
US-12342815-B2
View DetailsSystems and methods for providing a virtual machine link to process controls
US-12333323-B2
View Details
Combinations containing PVA and certain herbicides with improved properties
US-12342815-B2
View DetailsSystems and methods for providing a virtual machine link to process controls
US-12333323-B2
View DetailsProducts
Fungicide crop-protection formulations
Manufacture and formulation of fungicidal crop-protection products for worldwide distribution.
High-purity pharmaceutical active ingredients (APIs)
Production of high-purity pharmaceutical APIs and intermediates using integrated fermentation and chemical-processing workflows for downstream formulation.
Plant-based medicinal products (phytopharmaceuticals)
Development, manufacture and quality analysis of plant-extract-based medicinal products for self-medication and other indications produced at a dedicated phytopharmaceutical site.
Fungicide crop-protection formulations
Manufacture and formulation of fungicidal crop-protection products for worldwide distribution.
High-purity pharmaceutical active ingredients (APIs)
Production of high-purity pharmaceutical APIs and intermediates using integrated fermentation and chemical-processing workflows for downstream formulation.
Plant-based medicinal products (phytopharmaceuticals)
Development, manufacture and quality analysis of plant-extract-based medicinal products for self-medication and other indications produced at a dedicated phytopharmaceutical site.
Services
Operational execution of clinical studies and provision of a public trial search platform to connect patients and investigators.
On-site manufacturing of pharmaceutical active ingredients and crop-protection products, combining fermentation and chemical processing for global supply.
Deployment and integration of digital farming tools and partnerships to support precision agriculture and farm-management workflows.
Design, conduct and vendor oversight of in vivo safety and efficacy studies required for pharmaceutical and crop-protection development, typically using rodent models, with integrated animal-welfare programs and partner audits.
Systems for collecting, evaluating and reporting suspected adverse reactions and product quality complaints to health authorities, including public reporting channels and contact options.
Operational consulting and internal programs to implement product-supply frameworks and scale manufacturing capacity for increased production volumes.
Operational execution of clinical studies and provision of a public trial search platform to connect patients and investigators.
On-site manufacturing of pharmaceutical active ingredients and crop-protection products, combining fermentation and chemical processing for global supply.
Deployment and integration of digital farming tools and partnerships to support precision agriculture and farm-management workflows.
Design, conduct and vendor oversight of in vivo safety and efficacy studies required for pharmaceutical and crop-protection development, typically using rodent models, with integrated animal-welfare programs and partner audits.
Systems for collecting, evaluating and reporting suspected adverse reactions and product quality complaints to health authorities, including public reporting channels and contact options.
Operational consulting and internal programs to implement product-supply frameworks and scale manufacturing capacity for increased production volumes.
Expertise Areas
- Clinical trial management
- Clinical data transparency and sharing
- Pharmacovigilance and drug safety reporting
- Active pharmaceutical ingredient (API) manufacturing
Key Technologies
- Microbial fermentation
- Integrated chemical synthesis
- Genome editing
- AAV and viral-vector platforms
News & Updates
Bayer announced its second quarter results for 2025, highlighting financial performance.
Bayer announced its third quarter results for 2025, providing insights into business development.
The U.S. Food and Drug Administration has approved an additional indication for Bayer's prostate cancer drug Nubeqa®.
Bayer is ranked fifth in the world for brand value within its category, with a valuation of $6.22 billion according to Brand Finance.
Bayer announced its second quarter results for 2025, highlighting financial performance.
Bayer announced its third quarter results for 2025, providing insights into business development.
The U.S. Food and Drug Administration has approved an additional indication for Bayer's prostate cancer drug Nubeqa®.
Bayer is ranked fifth in the world for brand value within its category, with a valuation of $6.22 billion according to Brand Finance.